Value, Evidence and Access
Driving faster research in Health Economics and Outcomes Research (HEOR), Real World Evidence (RWE), Market Access, and Evidence-based Value Demonstration. We connect researchers and suppliers working with data and evidence to guide value-based decisions.
Healthcare is experiencing an evidence-centric paradigm shift that is changing the way decisions are made in pursuit of “value”. The fields of Health Economics and Outcomes Research (HEOR), Real World Evidence (RWE) and Market Access, collectively referred to as “Value, Evidence and Access”, are at the heart of this transformation due to the pivotal role they play in payer reimbursement, post-marketing safety surveillance and patient outcomes assessment within and outside randomized clinical trials.
As this need becomes increasingly vital, complex and multi-dimensional, it is imperative to find sourcing and procurement solutions that speed up delivery of commercially-relevant evidence.
Scientist.com supports the outsourcing of Value, Evidence and Access projects by helping buyers and sellers of these services establish external partnerships to address the critical business need, workload, regulatory pressures and talent gap, while improving the values of medicines available to patients across the globe.
Click the image below to download an insight survey on value communication in pharma.
50% of buyers agree it is challenging to find and compare potential suppliers1
71% of manufacturers outsource most or almost all of their HEOR work, due to limited internal resources, lack of time, and fostering greater credibility by using trusted third-party partners1
8/10 suppliers agree that it is difficult to navigate through the buyer’s procurement process1